Search
Search Results
##search.searchResults.foundPlural##
-
OCCULT HEPATITIS B VIRUS INFECTION AND ASSOCIATED GENOTYPES AMONG HBSAG-NEGATIVE SUBJECTS IN BURKINA FASO
4783PDF: 1288HTML: 513Figure: 290 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2479PDF: 1918HTML: 1081 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4220PDF: 1643HTML: 9330Untitled: 338Untitled: 232Untitled: 217Untitled: 223Untitled: 231Untitled: 390 -
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
2207PDF: 1149HTML: 999Figure 1: 216Figure 2: 238 -
-
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3516PDF: 1590HTML: 5981Fig1-Ag-Pil: 287Ag-Pil Fig.2: 288 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1433PDF: 1159HTML: 277 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1263PDF: 664Suppl. Files: 154HTML: 548 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1456PDF: 506HTML: 18639Figure 1: 207Figure 2: 191Figure 3: 206Figure 4: 243Figure 5: 212 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1916PDF: 1266HTML: 364 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4143PDF: 1137HTML: 3915Untitled: 205Cneo. Fig.1: 147Untitled: 138Untitled: 172Untitled: 175 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3497PDF: 1021HTML: 4963 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3817PDF: 2654HTML: 1693 -
-
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3293PDF: 964HTML: 7320Kost Fig1: 233Kost Fig 2: 220Kost Fig3: 234Kost Fig 4: 245Kost Fig5: 243Kost fig 6: 230 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5259PDF: 1382HTML: 1944Untitled: 235Untitled: 223 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
2500PDF: 659HTML: 386 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9511PDF: 6306HTML: 88323Fig.1b: 286Fig.1c: 294Fig.2a: 285Fig.2b: 263Fig.4: 305Fig.2c: 267Fig.3: 276Tab.1: 339Tab.2: 311Tab.3: 294Tab.4: 339Fig1a: 286 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3546PDF: 1624HTML: 4092 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1231PDF: 1251Suppl. Files: 607HTML: 115 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4708PDF: 1830HTML: 1366 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
624PDF: 311HTML: 158 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2475PDF: 1040HTML: 11179 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
3008PDF: 1243HTML: 11436 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1748HTML: 715PDF: 930 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1612PDF: 1034HTML: 456 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
5004PDF: 1953HTML: 2210 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2646PDF: 891HTML: 495 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2135PDF: 845HTML: 736Table1: patient's characteristics: 249Table 2: profile of each patient: 236







